Formulated for atopic dermatitis and psoriasis to alleviate skin inflammation and support lesion healing.
Mechanism of Action
Mometasone induces lipocortins, which inhibit phospholipase A2. This action blocks the release of arachidonic acid and suppresses the formation of prostaglandins and leukotrienes, reducing local inflammation.
Route of Administration
Topical
Onset Time
1–2 days
Duration
12–24 hours
Contraindications
Hypersensitivity to mometasone, Untreated skin infections
Severe Adverse Events
Adrenal suppression, Cushing's syndrome, Anaphylaxis — requires immediate medical attention
Information related to Elocon is compiled and periodically reviewed with reference to established medical sources and prescribing guidance. Content is provided for general reference and should be confirmed with a registered healthcare professional before use.
